159 related articles for article (PubMed ID: 23725228)
1. Clinical drug trials in general practice: a 10-year overview of protocols.
Brænd AM; Jensen KB; Klovning A; Straand J
Trials; 2013 Jun; 14():162. PubMed ID: 23725228
[TBL] [Abstract][Full Text] [Related]
2. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
[TBL] [Abstract][Full Text] [Related]
3. Publication and non-publication of drug trial results: a 10-year cohort of trials in Norwegian general practice.
Brænd AM; Straand J; Jakobsen RB; Klovning A
BMJ Open; 2016 Apr; 6(4):e010535. PubMed ID: 27067893
[TBL] [Abstract][Full Text] [Related]
4. Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.
Coffey CS; Levin B; Clark C; Timmerman C; Wittes J; Gilbert P; Harris S
Clin Trials; 2012 Dec; 9(6):671-80. PubMed ID: 23250942
[TBL] [Abstract][Full Text] [Related]
5. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.
Winther FO; Hole OP; Nitter-Hauge S
Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994
[TBL] [Abstract][Full Text] [Related]
8. General practice-based clinical trials in Germany - a problem analysis.
Hummers-Pradier E; Bleidorn J; Schmiemann G; Joos S; Becker A; Altiner A; Chenot JF; Scherer M;
Trials; 2012 Nov; 13():205. PubMed ID: 23136890
[TBL] [Abstract][Full Text] [Related]
9. [Clinical trials in Norway--completion and reporting are not satisfactory].
Sandaker L; Fjeld B; Reikvam A; Lislevand H; Madsen S
Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2888-90. PubMed ID: 15550958
[TBL] [Abstract][Full Text] [Related]
10. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
11. Potentially Inappropriate Prescribing to Older Patients: Criteria, Prevalence and an Intervention to Reduce It: The Prescription Peer Academic Detailing (Rx-PAD) Study - A Cluster-Randomized, Educational Intervention in Norwegian General Practice.
Rognstad S; Brekke M; Gjelstad S; Straand J; Fetveit A
Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):380-391. PubMed ID: 29753315
[TBL] [Abstract][Full Text] [Related]
12. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
13. Clinical drug trials in general practice: how well are external validity issues reported?
Brænd AM; Straand J; Klovning A
BMC Fam Pract; 2017 Dec; 18(1):113. PubMed ID: 29284407
[TBL] [Abstract][Full Text] [Related]
14. A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice--The Prescription Peer Academic Detailing (Rx-PAD) study [NCT00281450].
Straand J; Fetveit A; Rognstad S; Gjelstad S; Brekke M; Dalen I
BMC Health Serv Res; 2006 Jun; 6():72. PubMed ID: 16764734
[TBL] [Abstract][Full Text] [Related]
15. Funding oncology clinical trials: are cooperative group trials sustainable?
Seow HY; Whelan P; Levine MN; Cowan K; Lysakowski B; Kowaleski B; Snider A; Xu RY; Arnold A
J Clin Oncol; 2012 May; 30(13):1456-61. PubMed ID: 22454412
[TBL] [Abstract][Full Text] [Related]
16. General practitioners' prescriptions of benzodiazepines, Z-hypnotics and opioid analgesics for elderly patients during direct and indirect contacts. A cross-sectional, observational study.
Sundseth AC; Gjelstad S; Straand J; Rosvold EO
Scand J Prim Health Care; 2018 Jun; 36(2):115-122. PubMed ID: 29656692
[TBL] [Abstract][Full Text] [Related]
17. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials.
Safer DJ
J Nerv Ment Dis; 2002 Sep; 190(9):583-92. PubMed ID: 12357091
[TBL] [Abstract][Full Text] [Related]
18. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
19. Economic impact of industry-sponsored clinical trials of pharmaceutical products in Austria.
Walter E; Eichhober G; Voit M; Baumgartner C; Celedin A; Holzhauser C; Mraz B; Ornauer C; Pleiner-Duxneuner J; Ponner B; Presch I; Pum G; Tieben H; Weingartmann G; Baltic D; Bonitz W; Kaehler ST
J Med Econ; 2020 Jun; 23(6):566-574. PubMed ID: 32046538
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
